Infectious Diseases / Pediatrics / Primary Care

A Next Generation of Pneumococcal Disease Protection

CME: 1.5

December 30, 2021
/ Print / Reprints /
| Share More
/ Text Size+

Upon completion of this activity, participants should be able to:

  • Explain the rationale behind the development of next generation pneumococcal conjugate vaccines
  • Identify highest-risk groups who should receive PCV15 versus PCV20
  • Formulate strategies to engage patients in shared clinical decision-making per CDC recommendations


Post a comment to this article